Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

HIV-1 inhibitor

Li F, GoUa-Gaur R, Salzwedel K, Kilgore NR, Reddick M, MataUana C, Castillo A, Zoumplis D, Martin DE, Orenstein JM et al. (2003) PA-457 a potent HIV inhibitor that disrupts core condensation by targeting a late step in Gag processing. Proc Natl Acad SciUSA 100 13555-13560... [Pg.23]

The identification of the HIV-1-specific non-nucleoside reverse transcriptase inhibitors (NNRTIs) as a separate class of HIV inhibitors was heralded by the discovery of the tetrahydroimidazo[4,5,1 -// .][ 1,4]benzo-diazepin-2(l //)-onc and -thione (TIBO) derivatives (Fig. 7) [58,59] and 1 -(2-hydroxyethoxymethyl)-6-(phenylthio)thymine (HEPT) derivatives (Fig. 8) [60,61]. The first TIBO derivatives (R82150, R82913) were the first NNRTIs [58] postulated to act as inhibitors of HIV-1 RT [59], For the HEPT derivatives it became evident that they also interact specifically with HIV-1 RT after a number of derivatives (i.e., E-EPU, E-EBU, and E-EBU-dM) had been synthesized that were more active than HEPT itself [62,63]. Following HEPT and TIBO, several other compounds, i.e., nevirapine, pyridinone, and bis(heteroaryl)piperazine (BHAP), were... [Pg.323]

De Clercq E. HIV inhibitors targeted at the reverse transcriptase. AIDS Res Human Retrovir 1992 8 119-134. [Pg.332]

Two approaches that have been validated for HIV inhibitors, nucleoside 5 -phosphonates [48] and 1,3-dioxolane analogs [49] have proven unsuccessful when applied to HCV inhibitors. Phosphonodiphosphates have been synthesized and are incorporated by NS5B RdRp, but Vmax/Km for these chain terminators is 10-100-fold less than for ATP, and potency must be greatly improved for analogs of this type to have utility [50]. A small series of 1,3-dioxolanes also failed to afford active inhibitors of HCV, or HIV, despite the addition of a 5-methyl substituent to impose the desired conformational preference [51]. Ring expanded nucleobases [52,53] and AICAR analogs have also been synthesized as HCV inhibitors which provide only weak replicon activity [54]. [Pg.284]

The oxidative carbonylation of amines to give ureas is at present one of the most attractive ways for synthesizing this very important class of carbonyl compounds via a phosgene-free approach. Ureas find extensive application as agrochemicals, dyes, antioxidants, resin precursors, synthetic intermediates (also for the production of carbamates and isocyanates), and HIV-inhibitors. Many transition metals (incuding Au [244], Co [248,253-255], Cu [242], Mn [249,256-258], Ni [259], Rh [246,247,260-262], Ru [224,260,263] and especially Pd [219,225,226,264-276], and, more recently, W [277-283]) as well as main-group elements (such as sulfur [284-286] and selenium [287— 292]) have been reported to promote the oxidative carbonylation of amines, usually under catalytic conditions. In some cases, carbamates and/or oxamides are formed as byproducts, thus lowering the selectivity of the process. [Pg.259]

Castanospermine is a plant alkaloid isolated from the seeds of the Australian chestnut tree, Castanospermium australe. As with most anti-HIV inhibitors, the discovery of the compound predates the time of isolation of HIV-1. The compound inhibits a-glucosidase-1, and therefore normal processing of the glycopro-... [Pg.231]

Johnson, M. D., Hoesterey, B. L., and Anderson, B. D. 1994. Solubilization of a tripeptide HIV inhibitor using a combination of ionization and complexation with chemically modi ed cyclodexJrififciarm. Sci. [Pg.156]

In addition to the above examples, there are still a large number of bioactive natural products and various synthetic and semisynthetic enol-containing compounds that serve as potential and promising drugs for various therapeutic purposes such as the non-peptidyl HIV inhibitor Aptivus (tipranavir Section IV.1) and the third-generation tetracycline antibiotics (Section IV.H). The structure and function of the metal complexes of some... [Pg.584]

In the continuous quest for new generations of HIV inhibitors, Pfizer identified the thiosubstituted pyrones as a new class of non-peptidic protease inhibitors [97]. [Pg.151]

Fullerenes and their derivatives are of broad interest in various fields ranging from ferromagnetism [87] over their application as possible HIV inhibitors [88] to tumor-therapeutic active substance in biological systems [89]. Although C6o is insoluble in water, dissolution may be accomplished by using water-soluble polymers [90] or surfactant solutions containing amphiphilic block-copolymers [91], micelles or liposomes [92, 93]. The immobilization of... [Pg.61]

Indications Anticancer (stomach, colorectal, lung, prostate), arthritis, asthma, heart disease, HIV inhibitor. Treatment of dandruff, fungal infections (tinea versicolor), and seborrhea Category Antioxidant Trace element... [Pg.521]

HIV inhibitor treatment eventually leads to the selection of resistant mutations, one key reason being that the reverse transcriptase is error prone since it lacks the 3 exonuclease activity. Currently, combinatorial inhibitors with different protein targets, for example, two reverse transcriptase (RT) nucleoside inhibitors and one protease inhibitor (PI), are used in highly active antiretroviral... [Pg.50]


See other pages where HIV-1 inhibitor is mentioned: [Pg.96]    [Pg.13]    [Pg.313]    [Pg.142]    [Pg.302]    [Pg.21]    [Pg.595]    [Pg.64]    [Pg.942]    [Pg.1402]    [Pg.167]    [Pg.6]    [Pg.656]    [Pg.397]    [Pg.221]    [Pg.659]    [Pg.2501]    [Pg.581]    [Pg.934]    [Pg.201]    [Pg.246]    [Pg.312]    [Pg.313]    [Pg.398]    [Pg.1062]    [Pg.727]   
See also in sourсe #XX -- [ Pg.302 ]

See also in sourсe #XX -- [ Pg.942 ]

See also in sourсe #XX -- [ Pg.60 , Pg.61 ]

See also in sourсe #XX -- [ Pg.53 , Pg.137 , Pg.138 ]

See also in sourсe #XX -- [ Pg.255 ]

See also in sourсe #XX -- [ Pg.25 , Pg.942 ]

See also in sourсe #XX -- [ Pg.61 ]




SEARCH



Clarithromycin HIV-protease inhibitors

Cyclic urea, HIV protease inhibitor

Erythromycin HIV-protease inhibitors

Future Considerations for HIV-1 Protease Inhibitors

HIV integrase inhibitor

HIV protease inhibitors

HIV protease inhibitors as anti-AIDS drugs

HIV protease, nonpeptide inhibitors

HIV protease-inhibitor complexes

HIV proteinase inhibitors

HIV replication inhibitors

HIV-1 Entry inhibitors

HIV-1 IN inhibitor

HIV-1 IN inhibitor trifluoromethyl pharmacophore

HIV-1 attachment inhibitor

HIV-1 integrase inhibitors lithospermic acid A type

HIV-1 integrase inhibitors lithospermic acid B type

HIV-1 nucleoside reverse transcriptase inhibitors

HIV-1 protease-inhibitor binding dynamics and thermodynamics

HIV-1 reverse transcriptase inhibitors

HIV-I protease inhibitors

HIV-RT inhibitors

HIV-protease inhibitor saquinavir

Human immunodeficiency virus (HIV protease inhibitors

Inhibitor of HIV-1 reverse

Integramycin as HIV-integrase inhibitor

Lithospermic acid as HIV-1 integrase inhibitor

Look up the names of both individual drugs and their drug groups to access full information HIV-protease inhibitors

Merck s HIV protease inhibitor Crixivan

Non-Nucleoside HIV Integrase Inhibitors

Nonnucleoside inhibitor of HIV-1 reverse

Nonnucleoside inhibitor of HIV-1 reverse transcriptase

Nonpeptide inhibitors of HIV

Peptidomimetic inhibitors of HIV-1 protease

Phomasetin as HIV inhibitor

Protease inhibitors in HIV infection

Reverse transcriptase inhibitors in HIV infection

Roche HIV protease inhibitor

Structure-based analysis of HIV-1 protease-inhibitor binding

Sulfamide HIV-1 protease inhibitors

© 2024 chempedia.info